Nutrient regulation of inflammatory signalling in obesity and vascular disease

Clin Sci (Lond). 2021 Jul 16;135(13):1563-1590. doi: 10.1042/CS20190768.

Abstract

Despite obesity and diabetes markedly increasing the risk of developing cardiovascular diseases, the molecular and cellular mechanisms that underlie this association remain poorly characterised. In the last 20 years it has become apparent that chronic, low-grade inflammation in obese adipose tissue may contribute to the risk of developing insulin resistance and type 2 diabetes. Furthermore, increased vascular pro-inflammatory signalling is a key event in the development of cardiovascular diseases. Overnutrition exacerbates pro-inflammatory signalling in vascular and adipose tissues, with several mechanisms proposed to mediate this. In this article, we review the molecular and cellular mechanisms by which nutrients are proposed to regulate pro-inflammatory signalling in adipose and vascular tissues. In addition, we examine the potential therapeutic opportunities that these mechanisms provide for suppression of inappropriate inflammation in obesity and vascular disease.

Keywords: cardiovascular disease; hyperglycaemia; inflammation; obesity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adipokines / metabolism
  • Adipose Tissue / drug effects
  • Adipose Tissue / immunology
  • Adipose Tissue / metabolism*
  • Adipose Tissue / physiopathology
  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Cardiovascular Diseases / immunology
  • Cardiovascular Diseases / metabolism*
  • Cardiovascular Diseases / physiopathology
  • Cardiovascular Diseases / prevention & control
  • Cardiovascular System / drug effects
  • Cardiovascular System / immunology
  • Cardiovascular System / metabolism*
  • Cardiovascular System / physiopathology
  • Energy Metabolism* / drug effects
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Inflammation / drug therapy
  • Inflammation / immunology
  • Inflammation / metabolism*
  • Inflammation / physiopathology
  • Inflammation Mediators / antagonists & inhibitors
  • Inflammation Mediators / metabolism*
  • Nutritional Status*
  • Obesity / drug therapy
  • Obesity / immunology
  • Obesity / metabolism*
  • Obesity / physiopathology
  • Oxidative Stress
  • Signal Transduction

Substances

  • Adipokines
  • Anti-Inflammatory Agents
  • Hypoglycemic Agents
  • Inflammation Mediators